STAAR Surgical (NASDAQ:STAA) Shares Bought by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD raised its position in shares of STAAR Surgical (NASDAQ:STAA) by 9.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 35,613 shares of the medical instruments supplier’s stock after acquiring an additional 3,066 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in STAAR Surgical were worth $866,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. MetLife Investment Management LLC boosted its stake in STAAR Surgical by 6.3% during the 4th quarter. MetLife Investment Management LLC now owns 30,396 shares of the medical instruments supplier’s stock worth $738,000 after purchasing an additional 1,796 shares during the last quarter. Illinois Municipal Retirement Fund boosted its position in STAAR Surgical by 8.3% during the fourth quarter. Illinois Municipal Retirement Fund now owns 30,144 shares of the medical instruments supplier’s stock worth $732,000 after acquiring an additional 2,318 shares during the last quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych grew its stake in STAAR Surgical by 9.7% during the 4th quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych now owns 39,500 shares of the medical instruments supplier’s stock valued at $959,000 after acquiring an additional 3,500 shares in the last quarter. Hsbc Holdings PLC grew its stake in STAAR Surgical by 21.3% during the 4th quarter. Hsbc Holdings PLC now owns 21,160 shares of the medical instruments supplier’s stock valued at $513,000 after acquiring an additional 3,714 shares in the last quarter. Finally, HighTower Advisors LLC increased its holdings in shares of STAAR Surgical by 42.6% in the fourth quarter. HighTower Advisors LLC now owns 12,956 shares of the medical instruments supplier’s stock valued at $315,000 after purchasing an additional 3,871 shares during the last quarter. Institutional investors and hedge funds own 96.70% of the company’s stock.

STAAR Surgical Trading Down 0.9%

Shares of NASDAQ STAA opened at $19.36 on Monday. The stock has a market capitalization of $958.82 million, a PE ratio of -47.22 and a beta of 0.65. STAAR Surgical has a twelve month low of $13.50 and a twelve month high of $49.86. The stock has a fifty day simple moving average of $17.57 and a 200-day simple moving average of $21.86.

Wall Street Analyst Weigh In

STAA has been the subject of a number of recent research reports. StockNews.com downgraded STAAR Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, February 13th. Piper Sandler decreased their target price on shares of STAAR Surgical from $40.00 to $16.00 and set a “neutral” rating on the stock in a report on Wednesday, February 12th. Stephens reiterated an “equal weight” rating and issued a $17.00 price objective on shares of STAAR Surgical in a report on Tuesday, March 18th. Needham & Company LLC reissued a “hold” rating on shares of STAAR Surgical in a research note on Thursday, February 27th. Finally, Mizuho downgraded STAAR Surgical from an “outperform” rating to a “neutral” rating and reduced their target price for the company from $45.00 to $17.00 in a research report on Wednesday, February 12th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $24.63.

Insider Buying and Selling at STAAR Surgical

In other STAAR Surgical news, major shareholder Broadwood Partners, L.P. purchased 108,720 shares of the company’s stock in a transaction on Thursday, March 20th. The stock was acquired at an average price of $17.96 per share, for a total transaction of $1,952,611.20. Following the completion of the purchase, the insider now directly owns 12,182,995 shares in the company, valued at approximately $218,806,590.20. The trade was a 0.90% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders bought a total of 1,742,581 shares of company stock valued at $28,407,543 in the last three months. 1.00% of the stock is owned by corporate insiders.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.